Genetic polymorphism of MMP family and coronary disease susceptibility: A meta-analysis

Abilleira, 2006, The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis, J. Med. Genet., 43, 897, 10.1136/jmg.2006.040808 Alp, 2011, The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction, Genet. Test. Mol. Biomarkers, 15, 193, 10.1089/gtmb.2010.0113 Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 Beyzade, 2003, Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction, J. Am. Coll. Cardiol., 41, 2130, 10.1016/S0735-1097(03)00482-0 Colditz, 1995, Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary, Am. J. Epidemiol., 142, 371, 10.1093/oxfordjournals.aje.a117644 Cho, 2002, Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention, J. Hum. Genet., 47, 88, 10.1007/s100380200006 DerSimonian, 2007, Random-effects model for meta-analysis of clinical trials: an update, Contemp. Clin. Trials, 28, 105, 10.1016/j.cct.2006.04.004 Delgado-Enciso, 2009, Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population, J. Genet., 88, 249, 10.1007/s12041-009-0035-9 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Gao, 2004, Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 16, 536 Ghaderian, 2010, Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction, Coron. Artery Dis., 21, 330, 10.1097/MCA.0b013e32833ce065 Ghaderian, 2010, Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction, J. Thromb. Thrombolysis, 30, 404, 10.1007/s11239-010-0465-5 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 Humphries, 2002, Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men, Ann. Hum. Genet., 66, 343, 10.1046/j.1469-1809.2002.00126.x Haberbosch, 2005, Gelatinase B C(−1562)T polymorphism in relation to ischaemic heart disease, Scand. J. Clin. Lab. Invest., 65, 513, 10.1080/00365510500206575 Hlatky, 2007, Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease, Am. Heart J., 154, 1043, 10.1016/j.ahj.2007.06.042 Horne, 2007, Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease, Am. Heart J., 154, 751, 10.1016/j.ahj.2007.06.030 Han, 2008, Impact of matrix metalloproteinase-1 gene variations on risk of acute coronary syndrome, Coron. Artery Dis., 19, 227, 10.1097/MCA.0b013e3282f9d3d8 Han, 2008, Matrix metalloproteinase-1 gene -519A/G polymorphism and the risk of coronary heart disease in Northern Chinese Han population, Zhonghua Xin Xue Guan Bing Za Zhi, 36, 195 Kim, 2002, The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina, Yonsei Med. J., 43, 473, 10.3349/ymj.2002.43.4.473 Kaizar, 2005, Metaanalyses are observational studies: how lack of randomization impacts analysis, Am. J. Gastroenterol., 100, 1233, 10.1111/j.1572-0241.2005.50107.x Koh, 2008, A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction, Int. J. Cardiol., 127, 430, 10.1016/j.ijcard.2007.04.107 Koch, 2010, Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case–control study and a meta-analysis, Atherosclerosis, 208, 171, 10.1016/j.atherosclerosis.2009.08.021 Liu, 2006, Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome, Am. J. Cardiol., 98, 1012, 10.1016/j.amjcard.2006.05.017 Morgan, 2003, Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease, J. Mol. Med., 81, 321, 10.1007/s00109-003-0441-z Meng, 2006, Relationship between polymorphisms of matrix metalloproteinase and coronary heart disease, Tianjin. Med. J., 34, 295 Morgan, 2007, Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study, JAMA, 297, 1551, 10.1001/jama.297.14.1551 Ma, 2010, Interaction between matrix metalloproteinase-9 polymorphism and hypertension in relation to myocardial infarction in a Chinese population, Chin. J. Hypertens., 18, 1167 Nojiri, 2003, Genetic variations of matrix metalloproteinase-1 and −3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese, Int. J. Cardiol., 92, 181, 10.1016/S0167-5273(03)00100-1 Nuzzo, 2006, Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily, Ann. N. Y. Acad. Sci., 1089, 496, 10.1196/annals.1386.048 Nanni, 2007, Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms, Transl. Res., 149, 137, 10.1016/j.trsl.2006.09.001 Ozkök, 2008, Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients, Med. Sci. Monit., 14, CR536 Pearce, 2005, Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction, Circ. Res., 97, 1070, 10.1161/01.RES.0000189302.03303.11 Qin, 2005, Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome, Zhonghua Xin Xue Guan Bing Za Zhi, 33, 622 Román-García, 2009, Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case–control study in a Spanish population, Coron. Artery Dis., 20, 383, 10.1097/MCA.0b013e32832fa9cf Schwarz, 2002, The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease, Dis. Markers, 18, 121, 10.1155/2002/418383 Shioji, 2004, An association analysis between genetic polymorphisms of matrix metalloproteinase-3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese, J. Thromb. Haemost., 2, 527, 10.1111/j.1538-7933.2003.00595.x Samnegård, 2005, Serum matrix metalloproteinase-3 concentration is influenced by MMP-3–1612 5A/6A promoter genotype and associated with myocardial infarction, J. Intern. Med., 258, 411, 10.1111/j.1365-2796.2005.01561.x Shevchenko, 2010, Analysis of the gene polymorphism of matrix metalloproteinase-2 and −9 in patients with coronary heart disease, Ter. Arkh., 82, 31 Terashima, 1999, Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction, Circulation, 99, 2717, 10.1161/01.CIR.99.21.2717 Tobin, 2004, Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case–control study, Eur. Heart J., 25, 459, 10.1016/j.ehj.2003.11.014 Wang, 2001, Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis, Clin. Sci. (Lond.), 101, 87, 10.1042/CS20000317 Wang, 2007, Relationships study about polymorphism of matrix metalloproteinase-9 with coronary heart disease, J. Clin. Hematol., 20, 28 Wu, 2009, Haplotype analysis of the stromelysin-1 (MMP3) and gelatinase B (MMP9) genes in relation to coronary heart disease, Ann. Hum. Genet., 73, 404, 10.1111/j.1469-1809.2009.00522.x Yamada, 2002, Prediction of the risk of myocardial infarction from polymorphisms in candidate genes, N. Engl. J. Med., 347, 1916, 10.1056/NEJMoa021445 Ye, 2003, Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease, Eur. Heart J., 24, 1668, 10.1016/S0195-668X(03)00385-3 Zhou, 2004, Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study, Thromb. Haemost., 92, 867, 10.1160/TH04-03-0192 Zhi, 2010, Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population, Mol. Biol. Rep., 37, 13, 10.1007/s11033-009-9482-x